Pyxis Oncology Inc. (PYXS)
undefined
undefined%
At close: undefined
1.63
0.07%
After-hours Dec 13, 2024, 07:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue - - - - -
Cost of Revenue 2.00M 1.84M 1.25M 444.00K -
Gross Profit -2.00M -1.84M -1.25M -444.00K -
Operating Income -82.20M -123.48M -69.72M -12.89M -2.88M
Interest Income 6.63M 2.76M 23.00K 66.00K 107.00K
Pretax Income -73.79M -120.72M -75.97M -12.83M -2.77M
Net Income -73.79M -117.95M -81.54M -12.76M -2.67M
Selling & General & Admin 32.61M 37.35M 18.66M 3.85M 1.66M
Research & Development 49.59M 86.13M 51.05M 9.05M 1.22M
Other Expenses - - 181.00K - -
Operating Expenses 82.20M 123.48M 69.72M 12.89M 2.88M
Interest Expense - - - - -
Selling & Marketing Expenses - - - - -
Cost & Expenses 82.20M 123.48M 69.72M 12.89M 2.88M
Income Tax - -2.76M 5.56M -66.00K -107.00K
Shares Outstanding (Basic) 39.90M 33.03M 32.22M 34.31M 34.31M
Shares Outstanding (Diluted) 39.90M 33.03M 32.22M 34.31M 34.31M
EPS (Basic) -1.85 -3.57 -2.53 -0.37 -0.08
EPS (Diluted) -1.85 -3.57 -2.53 -0.37 -0.08
EBITDA -78.49M -122.77M -69.07M -12.43M -
Depreciation & Amortization 2.00M 1.84M 1.25M 444.00K 2.88M